Hermann L. Müller | Medicine and Dentistry | Women Researcher Award

Published on by Phenomenological Research Awards

Prof. Dr. Hermann L Muller | Medicine and Dentistry | Women Researcher Award

M.D at Klinikum Oldenburg AöR Medical Campus University Oldenburg | Germany

Prof. Dr. Hermann L. Müller is a distinguished pediatrician and academic leader based in Germany. He currently serves as Professor of Pediatrics and Head of the Department of Pediatrics and Pediatric Hematology and Oncology at Klinikum Oldenburg, part of the European Medical School Oldenburg-Groningen. With a career dedicated to advancing pediatric care, Dr. Müller has made significant strides in pediatric oncology and endocrinology, particularly in the study of childhood craniopharyngioma. His collaborative efforts in multinational clinical trials and leadership roles in international societies reflect his commitment to improving treatment outcomes and quality of life for pediatric patients globally.

Profile:

 Orcid

Education:

Prof. Dr. Hermann L. Müller began his medical training in general pediatrics at the University of Marburg and the University of Würzburg, Germany. He further honed his clinical and research expertise through a prestigious post-doctoral fellowship at Stanford University Medical Center under Prof. Dr. Ron Rosenfeld from 1991 to 1993. Following his time in the U.S., he specialized in pediatric oncology, hematology, endocrinology, and diabetology at the Department of Pediatrics, University of Würzburg. His educational trajectory reflects a deep interdisciplinary foundation that has propelled his pioneering work in pediatric neuro-oncology and endocrinology.

Experience:

With decades of clinical and academic experience, Prof. Dr. Hermann L. Müller has served as a leading figure in pediatric medicine. Since 1999, he has been coordinating major clinical trials, including the German/European craniopharyngioma trials HIT-ENDO and KRANIOPHARYNGEOM 2000/2007, involving over 590 patients across Germany, Austria, and Switzerland. Between 2004 and 2011, he was the speaker for the Craniopharyngioma Subgroup of the International Society of Paediatric Oncology (SIOP). At Klinikum Oldenburg, he leads a team dedicated to pediatric hematology, oncology, and endocrinology, integrating clinical excellence with teaching at the Carl von Ossietzky University of Oldenburg.

Research Interest:

Prof. Dr. Hermann L. Müller’s research is centered on the late effects of pediatric oncological diseases, neuro-endocrinology, and hypothalamic disorders. He has a special focus on craniopharyngioma—a rare brain tumor affecting children—and the associated complications such as hypothalamic obesity and disrupted satiety regulation. His work explores both diagnostic methodologies and therapeutic interventions for these conditions, emphasizing long-term patient outcomes and quality of life. Through clinical trials and translational research, he has significantly advanced the understanding of hypothalamic dysfunction and the neuroendocrine sequelae of childhood brain tumors.

Awards and Honors:

Prof. Dr. Hermann L. Müller’s contributions to pediatric oncology and endocrinology have earned him significant recognition within the scientific community. While specific awards are not detailed in the provided CV, his longstanding leadership in European and international clinical trials, coupled with his role in academic pediatric medicine, underscores his stature as a leading expert. His coordination of landmark studies, such as HIT-ENDO, and representation in global professional societies further attest to his impact. His nomination for an award acknowledges both his scientific rigor and his commitment to improving care for children with complex neuro-oncological conditions.

Publications Top Notes:

Title: Childhood craniopharyngioma: treatment strategies and outcomes

Citations: 498

Year of Publication: 2014

Title: Craniopharyngioma and hypothalamic injury: Latest insights into consequent eating disorders and obesity

Citations: 120

Year of Publication: 2016

Title: Management of Hypothalamic Obesity

Citations: 45

Year of Publication: 2020

Title: Craniopharyngioma a chronic disease

Citations: 11

Year of Publication: 2018

Title: Preoperative staging in childhood craniopharyngioma: standardization as a first step towards improved outcome

Citations: 53

Year of Publication: 2016

Title: A systematic review of cognitive performance in patients with childhood craniopharyngioma

Citations: 66

Year of Publication: 2015

Conclusion:

Prof. Dr. Hermann L. Müller stands as a global authority in pediatric oncology and neuro-endocrinology, with a career marked by innovation, leadership, and compassion. His extensive clinical experience, coupled with an exceptional research portfolio and educational contributions, reflects a lifelong dedication to improving pediatric healthcare. His pioneering studies on craniopharyngioma and hypothalamic disorders have transformed treatment approaches and informed international guidelines. Recognizing his achievements through this award would honor a professional who has profoundly impacted children’s lives and fostered meaningful international collaborations in pediatric medicine.

Ivan Hancco Zirena | Medicine and Dentistry | Lifetime achievement Award

Published on by Phenomenological Research Awards

Prof.Dr.Ivan Hancco Zirena | Medicine and Dentistry | Lifetime achievement Award

post doc at Harvard Medical School, Peru.

Dr. Ivan Hancco Zirena is a distinguished Peruvian physician and researcher specializing in clinical hematology, physiology, and high-altitude medicine. With a rich academic and clinical background spanning multiple continents, Dr. Hancco has carved a niche in understanding human adaptation to hypoxia and extreme environments. Currently serving as a postdoctoral researcher at the Thrombosis and Hemostasis Unit at Harvard Medical School’s Beth Israel Deaconess Medical Center, he contributes to groundbreaking studies on coagulation, red cell physiology, and novel antithrombotic agents.

Profile:

🎓 Educational Background:

Dr. Hancco earned his M.D. from the Universidad Nacional del Altiplano in Puno, Peru (2003), and later specialized in Hematology at Universidad Ricardo Palma, Lima. He pursued advanced studies in France, completing a Master’s in Integrated Biology and Physiology at Université Claude Bernard Lyon 1, followed by a Ph.D. in Physiology at Université Grenoble Alpes. His doctoral thesis investigated hematological responses in high-altitude populations living above 5,000 meters, under the supervision of Dr. Samuel Verges. He is currently completing a postdoctoral fellowship at Harvard Medical School (2023–2025).

💼 Professional Experience:

Dr. Hancco brings extensive experience in both clinical and academic medicine. He has worked in emergency care, hematology units, and cardiovascular rehabilitation in Peru, France, and Spain. His research roles at Laboratoire HP2 (France) and currently at Harvard Medical School (USA) have sharpened his focus on high-impact clinical studies. Additionally, he has provided care to patients with benign and malignant hematologic diseases in military and public hospitals.

Research Interests:

Dr. Hancco’s primary research explores the physiological and hematological adaptations to hypoxia, chronic mountain sickness, erythrocytosis, and cardiovascular and thrombotic responses at high altitudes. His recent work delves into the role of thiol isomerases in hemostasis and thrombosis, with applications in vascular medicine and novel antithrombotic therapies. His interdisciplinary approach bridges physiology, hematology, environmental medicine, and cellular biology.

Teaching Experience:

A passionate educator, Dr. Hancco has taught hematology, physiology, and molecular biology at top Peruvian universities including Universidad de San Martín de Porres, Universidad Científica del Sur, and Universidad Nacional del Altiplano. He has led student research groups, facilitated international exchange programs, and integrated research into medical training. His teaching style fosters critical thinking, debate, and hands-on learning in laboratory and clinical environments.

Skills:

Dr. Hancco is skilled in a wide array of biomedical techniques including flow cytometry, cell culture, platelet aggregation, protein purification, magnetic cell levitation, cytokinesis analysis, microscopy, and complete blood count analysis. These tools have supported his innovative research in hypoxia and hemostasis.

🏅 Recognition and Impact:

Dr. Hancco’s research on chronic mountain sickness and thrombosis has global relevance, particularly for populations living in extreme altitudes. His findings contribute to improved diagnostic and therapeutic strategies for hematological disorders in both high- and low-altitude settings. His work has earned him collaboration with world-renowned institutions and recognition as a rising figure in global hematology and physiology.

Publications:

  • Galloylated polyphenols represent a new class of antithrombotic agents with broad activity against thiol isomerases.
    Journal of Thrombosis and Haemostasis, 2025.

  • Cerebral blood flow in Andean children and adolescents living above 5,000 m.
    Journal of Neurophysiology, 2025.

  • Neurological manifestations associated with exercise at altitude.
    Current Neurology and Neuroscience Reports, 2025.

  • Pain perception threshold in young high-altitude natives after acute exposure to severe hypoxic conditions.
    Oxygen (Basel), 2025.

  • Micro- and macrovascular function in the highest city in the world: A cross-sectional study.
    Lancet Regional Health – Americas, 2024.

  • Performance in the six-minute walking test does not discriminate excessive erythrocytosis patients in a severe hypoxic environment.
    International Journal of Environmental Research and Public Health, 2024.

  • Expedition 5300: Limits of human adaptations in the highest city in the world.
    Journal of Physiology, 2024.

  • Cerebral homeostasis and orthostatic responses in residents of the highest city in the world.
    Scientific Reports, 2024.

  • Lower glycemia levels in subjects with excessive erythrocytosis during the oral glucose tolerance test living in conditions of severe hypoxia.
    Frontiers in Physiology, 2024.

  • Are coagulation profiles in Andean highlanders with excessive erythrocytosis favouring hypercoagulability?
    Experimental Physiology, 2024.

Nazanin mahinparvar | Medicine | Best Researcher Award

Published on by Phenomenological Research Awards

Nazanin mahinparvar | Medicine | Best Researcher Award

Postdoc at Stanford university, United States.

Dr. Nazanin Mahinparvar is a postdoctoral scholar at Stanford University, focusing on bioengineering and pain management. She brings a blend of medical and research expertise to her work, aiming to develop innovative gene therapies that offer non-addictive, effective treatments for chronic pain. Her research in synthetic biology, combined with her clinical background as an emergency medicine physician, underscores her commitment to translating laboratory discoveries into practical healthcare solutions. Throughout her career, she has received numerous accolades for her dedication to patient care and research excellence, including the Best Physician Award during the COVID-19 pandemic. Her approach to research is driven by a patient-centered perspective, making her work both scientifically rigorous and highly relevant to addressing current health challenges. Dr. Mahinparvar’s focus on developing HSV-based biotechnologies has the potential to reshape pain management therapies, positioning her as a significant contributor to advancements in medical science.

Profile👤

Scopus

Education 🎓

Dr. Nazanin Mahinparvar’s educational journey is marked by excellence and a clear dedication to advancing medical knowledge. She began her studies in Biology at SAMPAD in Iran, followed by an MD at Isfahan Medical University, where she was recognized with high honors. Her medical education included an emphasis on pain management, an area she explored further during her mandatory medical service program. Her commitment to lifelong learning and research brought her to Stanford University for a prestigious postdoctoral position in bioengineering. Dr. Mahinparvar’s educational background integrates both foundational medical training and specialized knowledge in synthetic biology and gene therapy. Her academic journey has been marked by a strong interdisciplinary focus, with formal training that spans basic sciences, clinical practice, and cutting-edge bioengineering. This diverse educational foundation provides her with a unique perspective, enabling her to bridge the gap between laboratory research and patient-centered clinical applications.

Experience💼

Dr. Nazanin Mahinparvar has extensive experience in both clinical and research settings, blending hands-on patient care with innovative scientific research. Her early career as a physician involved managing healthcare in underserved areas, where she was honored with the Best Doctor Award for her exceptional patient care. Following this, she served as an emergency medicine physician, honing her ability to operate under pressure. During her postdoctoral work at Stanford, she focused on developing non-toxic HSV-based therapies for chronic pain and neurological disorders. Her clinical experience in pain management, coupled with her research in gene therapy and synthetic biology, has positioned her as a leader in innovative medical research. Dr. Mahinparvar’s experience is a blend of practical and scientific expertise, which she continually refines through collaboration with top scientists and participation in clinical trials. Her background uniquely equips her to drive impactful advancements in pain management and gene-based therapies.

Research Interests 🔬

Dr. Mahinparvar’s research interests focus on engineering advanced, safe, and efficient gene therapies for chronic pain and neurological disorders. She specializes in developing non-addictive pain management treatments using synthetic biology and gene engineering, with a particular interest in non-toxic HSV-based technologies. Dr. Mahinparvar’s work aims to address global health challenges by providing affordable, accessible solutions for conditions that currently lack effective, low-risk treatments. At Stanford’s Wu Tsai Neurosciences Institute, her research delves into combining gene therapy with bioengineering to create precise, targeted interventions. Her early research on selenium’s effects on respiratory functions in ICU patients sparked her interest in translational medicine, which she has expanded to chronic pain and neuro-oncology applications. Dr. Mahinparvar’s research is ultimately driven by her commitment to improving patient outcomes and advancing the field of pain management through innovative, cross-disciplinary approaches that bridge the laboratory and the clinic.

Awards and Honors 🏆

Throughout her career, Dr. Mahinparvar has earned multiple awards recognizing her excellence in both research and clinical practice. In 2021, she received the Best Physician Award for her dedication to patient care during the COVID-19 pandemic, reflecting her commitment to providing quality healthcare under challenging conditions. She was also honored with the Foundation of Future Medical Research Fellowship at the Kheradmand Institute, which brought her to Stanford for advanced research in head and neck surgery and gene therapy. Other accolades include her high-honors MD dissertation award and the Best Student Award from Iran’s SAMPAD organization for exceptional talent. These recognitions highlight Dr. Mahinparvar’s leadership, resilience, and contribution to medicine. Her awards underscore her determination to push the boundaries of traditional pain management, making her a strong candidate for future honors in the fields of bioengineering and clinical research.

Conclusion 🔚 

Dr. Mahinparvar’s academic and clinical achievements, including her innovative work in chronic pain management, place her among the most promising candidates for the Best Researcher Award. Her interdisciplinary research, combined with her commitment to patient care and clinical applications, demonstrates her potential to make lasting contributions to medical science and public health. This award would provide well-deserved recognition and support to advance her impactful research on a global scale.

Publications Top Notes 📚

Title: Oxytocin Receptors on Calvarial Periosteal Innervation: Therapeutic Target for Post-Traumatic Headache?
Authors: Bharadwaj, V.N., Klukinov, M., Cowan, R.P., Mahinparvar, N., Clark, D.J., Yeomans, D.C.
Year: 2024
Journal: Pharmaceutics, 16(6), 760
Citation Count: 0

Title: Chemopreventive and therapeutic potential of curcumin in esophageal cancer: Current and future status
Authors: Hesari, A., Azizian, M., Sheikhi, A., Nesaei, A., Sanaei, S., Mahinparvar, N., Derakhshani, M., Hedayt, P., Ghasemi, F., Mirzaei, H.
Year: 2019
Journal: International Journal of Cancer, 144(6), pp. 1215–1226
Citation Count: 103

Title: Cyclophosphamide versus rituximab in progressive forms of multiple sclerosis
Authors: Etemadifar, M., Ghourchian, S., Mahinparvar, N., Sanaei, S., Akbari, M.
Year: 2019
Journal: Acta Medica Iranica, 57(8), pp. 484–491
Citation Count: 2

Title: Comparison of the efficacy of midazolam and dexmedetomidine in quality of sedation in mechanically-ventilated patients admitted to intensive care unit
Authors: Kashefi, P., Mahinparvar, N., Khalifsoltani-Khajooie, M., Mansouri, P., Sanaei, S.
Year: 2018
Journal: Journal of Isfahan Medical School, 35(460), pp. 1799–1805
Citation Count: 1

Title: The effect of selenium on maximum inspiratory pressure in patients under mechanical ventilation in intensive care units
Authors: Alikiaii, B., Mahinparvar, N.
Year: 2017
Journal: Journal of Isfahan Medical School, 35(423), pp. 291–296
Citation Count: 1